Pathophysiological mechanisms contributing to renal dysfunction in chronic heart failure

Journal of Renal Care

Volumn 36, Issue SUPPL. 1, 2010, Pages 18-26

  Damman, Kevin ^a   Kalra, Paul R ^b   Hillege, Hans ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Cardiorenal; Chronic kidney disease; Heart failure

Indexed keywords

CREATININE;

ANEMIA; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEEDBACK SYSTEM; GLOMERULUS; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEMODYNAMICS; HUMAN; KIDNEY CIRCULATION; KIDNEY TUBULE; MORTALITY; NURSING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SURVIVAL RATE;

ANEMIA; CREATININE; FEEDBACK, PHYSIOLOGICAL; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMODYNAMICS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TUBULES; PROGNOSIS; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SURVIVAL RATE;

EID: 77952569787     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2010.00172.x     Document Type: Article

References (58)

1. Anker S.D., Comin Colet J., Filippatos G. et al 2009). Ferric carboxy-maltose in patients with heart failure and iron deficiency. The New England Journal of Medicine 361 (25 2436 2448.
2. Benedict C.R., Francis G.S., Shelton B. et al 1995). Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators. The American Journal of Cardiology 75, 1151 1157.
3. Blake W.D., Wegria R., Keating R.P. et al 1949). Effect of increased renal venous pressure on renal function. The American Journal of Physiology 157, 1 13.
4. Bongartz L.G., Cramer M.J., Doevendans P.A. et al 2005). The severe cardiorenal syndrome: 'Guyton revisited.' European Heart Journal 26, 11 17.
5. Cody R.J., Ljungman S., Covit A.B. et al 1998). Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney International 34, 361 367.
6. Costanzo M.R., Saltzberg M., O'Sullivan J. et al 2005). Early ultrafil-tration in patients with decompensated heart failure and diuretic resistance. Journal of the American College of Cardiology 46, 2047 2051.
7. Creager M.A., Halperin J.L., Bernard D.B. et al 1981). Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation 64, 483 489.
8. Damman K., Navis G., Voors A.A. et al 2007a). Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. Journal of Cardiac Failure 13, 599 608.
9. Damman K., Navis G., Smilde T.D. et al 2007b). Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. European Journal of Heart Failure 9, 872 878.
10. Damman K., van Veldhuisen D.J., Navis G. et al 2008). Urinary neu-trophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. European Journal of Heart Failure 10, 997 1000.
11. Damman K., van Deursen V.M., Navis G. et al 2009a). Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. Journal of the American College of Cardiology 53, 582 588.
12. Damman K., van Veldhuisen D.J., Navis G. et al 2009b). Tubular damage is common and associated with reduced survival in patients with chronic heart failure. Journal of the American College of Cardiology 53, A162 A162.
13. Danser A.H., Batenburg W.W. van Esch J.H. (2007). Prorenin and the (pro)renin receptor-an update. Nephrology, Dialysis, Transplantation 22, 1288 1292.
14. DiBona G.F. (2000). Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 36, 1083 1088.
15. Dickstein K., Cohen-Solal A., Filippatos G. et al 2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 29, 2388 2442.
16. Ding H., He Y, Li K. et al 2007). Urinary neutrophil gelatinase- associated lipocalin (NGAL) is an early biomarker for renal tubu-lointerstitial injury in IgA nephropathy. Clinical Immunology 123, 227 234.
17. Doty J.M., Saggi B.H., Sugerman H.J. et al 1999). Effect of increased renal venous pressure on renal function. The Journal of Trauma 47, 1000 1003.
18. Doty J.M., Saggi B.H., Blocher C.R. et al 2000). Effects of increased renal parenchymal pressure on renal function. The Journal of Trauma 48, 874 877.
19. Ellison D.H. (2001). Diuretic therapy and resistance in congestive heart failure. Cardiology 96, 132 143.
20. Fischer D., Rossa S., Landmesser U. et al 2005). Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. European Heart Journal 26, 65 69.
21. Fiksen-Olsen M.J., Strick D.M., Hawley H. et al 1992). Renal effects of angiotensin II inhibition during increases in renal venous pressure. Hypertension 19, 137 141.
22. Go A.S., Chertow G.M., Fan D. et al 2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England Journal of Medicine 351, 1296 1305.
23. Gottlieb S.S., Dickstein K., Fleck E. et al 1993). Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation 88, 1602 1609.
24. Groenveld H.F, Januzzi J.L., Damman K. et al 2008). Anemia and mortality in heart failure patients a systematic review and meta-analysis. Journal of the American College of Cardiology 52, 818 827.
25. Hillege H.L., Girbes A.R., de Kam P.J. et al 2000). Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102, 203 210.
26. Hillege H.L., Nitsch D., Pfeffer M.A. et al 2006). Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113, 671 678.
27. Kalra PR., Anker A.D. Coats A.J. (2001). Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin. Cardiovascular Research 51, 495 509.
28. Kalra PR., Bolger A.P., Francis D.P. et al 2003). Effect of anemia on exercise tolerance in chronic heart failure in men. The American Journal of Cardiology 91, 888 891.
29. Kastner PR., Hall J.E. Guyton A.C. (1982). Renal hemodynamic responses to increased renal venous pressure: role of angiotensin II. The American Journal of Physiology 243, F260 F264.
30. Kilcoyne M.M., Schmidt D.H. Cannon P.J. (1973). Intrarenal blood flow in congestive heart failure. Circulation 47, 786 797.
31. Krebs C., Hamming I., Sadaghiani S. et al 2007). Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney International 72, 725 730.
32. Leithe M.E., Margorien R.D., Hermiller J.B. et al 1984). Relationship between central hemodynamics and regional blood-flow in normal subjects and in patients with congestive heart-failure. Circulation 69, 57 64.
33. Liangos O., Perianayagam M.C., Vaidya VS. et al 2007). Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. Journal of the American Society of Nephrology 18, 904 912.
34. London G.M., Guerin A.P., Marchais S.J. et al 2003). Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrology, Dialysis Transplantation 18, 1731 1740.
35. Ljungman S., Laragh J.H. Cody, R.J. (1990). Role of the kidney in congestive heart-failure - relationship of cardiac index to kidney-function. Drugs 39, 10 21.
36. Maxwell M.H., Breed E.S. Schwartz I.L. (1950). Renal venous pressure in chronic congestive heart failure. The Journal of Clinical Investigation 29, 342 348.
37. Mullens W., Abrahams Z., Skouri H.N. et al 2008a). Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? Journal of the American College of Cardiology 51, 300 306.
38. Mullens W., Abrahams Z., Francis G.S. et al 2008b). Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. Journal of Cardiac Failure 14, 508 514.
39. Muntner P., Hamm L.L., Kusek J.W. et al 2004). The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Annals of Internal Medicine 140, 9 17.
40. Nanas J.N., Matsouka C, Karageorgopoulos D. et al 2006). Etiology of anemia in patients with advanced heart failure. Journal of the American College of Cardiology 48, 2485 2489.
41. Nohria A., Hasselblad V, Stebbins A. et al 2008). Cardiorenal interactions: insights from the ESCAPE trial. Journal of the American College of Cardiology 51, 1268 1274.
42. Norman J.T. Fine L.G. (2006). Intrarenal oxygenation in chronic renal failure. Clinical Experimental Pharmacology and Physiology 33, 989 996.
43. Opasich C., Cazzola M., Scelsi L. et al 2005). Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. European Heart Journal 26, 2232 2237.
44. Packer M. (1992). The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. Journal of the American College of Cardiology 20, 248 254.
45. Petrie M.C., Padmanabhan N., McDonald J.E. et al 2001). Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Journal of the American College of Cardiology 37, 1056 1061.
46. Raggi P., Boulay A., Chasan-Taber S. et al 2002). Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? Journal of the American College of Cardiology 39, 695 701.
47. Ronco C., Haapio M., House A.A. et al 2008). Cardiorenal syndrome. Journal of the American College of Cardiology 52, 1527 1539.
48. Seymour W.B., Pritchard W.H., Longley L.P. et al 1942). Cardiac output, blood and interstitial fluid volumes, total circulating serum protein, and kidney function during cardiac failure and after improvement. Journal of Clinical Investigation 21, 229 240.
49. Shlipak M.G., Fried L.F, Crump C. et al 2003). Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107, 87 92.
50. Silverberg D.S., Wexler D., Blum M. et al 2003). The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clinical Nephrology 60 (Suppl 1 S93 S102.
51. Smilde T.D., van Veldhuisen D.J., Navis G. et al 2006). Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114, 1572 1580.
52. Smilde T.D.J., Damman K. Van Der Harst P.I. (2009). Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clinical Research in Cardiology 98, 121 129.
53. Smith G.L., Lichtman J.H., Bracken M.B. et al 2006). Renal impairment and outcomes in heart failure: systematic review and meta-analysis. Journal of the American College of Cardiology 47, 1987 1996.
54. Tonelli M., Wiebe N., Culleton B. et al 2006). Chronic kidney disease and mortality risk: a systematic review. Journal of the American Society of Nephrology 17, 2034 2047.
55. Vallon V., Miracle C. Thomson S. (2008). Adenosine and kidney function: potential implications in patients with heart failure. European Journal of Heart Failure 10, 176 187.
56. Weber K.T. (1997). Extracellular matrix remodelling in heart failure: a role for de novo angiotensin II generation. Circulation 96, 4065 4082.
57. Weinfeld M.S., Chertow G.M. Stevenson L.W. (1999). Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. American Heart Journal 138, 285 290.
58. Zachariah D., Kalra PA. Kalra PR. (2009). Optimal management of chronic heart failure in patients with chronic kidney disease. Journal of Renal Care 35, 2 10.